Danielle Antalffy
Stock Analyst at UBS
(3.65)
# 809
Out of 4,955 analysts
179
Total ratings
51.43%
Success rate
6.03%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintains: Neutral | $94 → $95 | $92.71 | +2.47% | 11 | Aug 20, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $8.6 → $6.5 | $7.71 | -15.69% | 7 | Aug 8, 2025 | |
| RXST RxSight | Maintains: Neutral | $16 → $8 | $9.28 | -13.79% | 4 | Aug 8, 2025 | |
| ENOV Enovis | Maintains: Buy | $65 → $57 | $31.44 | +81.30% | 2 | Aug 8, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $91 → $96 | $107.71 | -10.87% | 5 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $20 → $17 | $11.93 | +42.50% | 15 | Aug 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Buy | $270 → $230 | $95.99 | +139.61% | 6 | Aug 5, 2025 | |
| BAX Baxter International | Maintains: Neutral | $35 → $24 | $24.54 | -2.20% | 6 | Aug 4, 2025 | |
| GKOS Glaukos | Maintains: Buy | $125 → $134 | $94.15 | +42.33% | 2 | Jul 31, 2025 | |
| DXCM DexCom | Maintains: Buy | $105 → $106 | $82.26 | +28.86% | 9 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $130 → $135 | $106.17 | +27.15% | 13 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $547 → $585 | $476.16 | +22.86% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $180 → $190 | $179.29 | +5.97% | 5 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $37.61 | +54.23% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $16 | $14.81 | +9.72% | 4 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $5 | $4.24 | +17.92% | 2 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $132.59 | +11.62% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $394.22 | -6.14% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $75 | $81.83 | -8.35% | 12 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $1.52 | +48.03% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $280 | $330.77 | -15.35% | 12 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $14.11 | +5,746.92% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $16.26 | -13.90% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $58.21 | +71.79% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $8.99 | +33.48% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $30 | $41.23 | -27.24% | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $37.18 | +21.03% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $199.66 | +37.73% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $4.89 | +309.00% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $7.80 | +438.46% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $3 | $0.46 | +555.88% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.93 | +1,511.69% | 1 | Sep 1, 2020 |
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94 → $95
Current: $92.71
Upside: +2.47%
Treace Medical Concepts
Aug 8, 2025
Maintains: Neutral
Price Target: $8.6 → $6.5
Current: $7.71
Upside: -15.69%
RxSight
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $9.28
Upside: -13.79%
Enovis
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $31.44
Upside: +81.30%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Sell
Price Target: $91 → $96
Current: $107.71
Upside: -10.87%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $11.93
Upside: +42.50%
Inspire Medical Systems
Aug 5, 2025
Maintains: Buy
Price Target: $270 → $230
Current: $95.99
Upside: +139.61%
Baxter International
Aug 4, 2025
Maintains: Neutral
Price Target: $35 → $24
Current: $24.54
Upside: -2.20%
Glaukos
Jul 31, 2025
Maintains: Buy
Price Target: $125 → $134
Current: $94.15
Upside: +42.33%
DexCom
Jul 31, 2025
Maintains: Buy
Price Target: $105 → $106
Current: $82.26
Upside: +28.86%
Jul 24, 2025
Maintains: Buy
Price Target: $130 → $135
Current: $106.17
Upside: +27.15%
Jul 23, 2025
Maintains: Neutral
Price Target: $547 → $585
Current: $476.16
Upside: +22.86%
Jul 17, 2025
Maintains: Buy
Price Target: $180 → $190
Current: $179.29
Upside: +5.97%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $37.61
Upside: +54.23%
Apr 29, 2025
Maintains: Neutral
Price Target: $19 → $16
Current: $14.81
Upside: +9.72%
Jan 27, 2025
Maintains: Buy
Price Target: $5.5 → $5
Current: $4.24
Upside: +17.92%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $132.59
Upside: +11.62%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $394.22
Upside: -6.14%
Sep 10, 2024
Maintains: Neutral
Price Target: $90 → $75
Current: $81.83
Upside: -8.35%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $1.52
Upside: +48.03%
May 6, 2022
Maintains: Outperform
Price Target: $300 → $280
Current: $330.77
Upside: -15.35%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $14.11
Upside: +5,746.92%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $16.26
Upside: -13.90%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $58.21
Upside: +71.79%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $8.99
Upside: +33.48%
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $41.23
Upside: -27.24%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $37.18
Upside: +21.03%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $199.66
Upside: +37.73%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $4.89
Upside: +309.00%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $7.80
Upside: +438.46%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $3
Current: $0.46
Upside: +555.88%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.93
Upside: +1,511.69%